跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 563 条关于
“Nucala (mepolizumab)”
全部
563
临床试验
415
药物
29
机构
12
资讯
107
2年前
GSK's Depemokimab Shows Promise in Reducing Severe Asthma Exacerbations
去年
GSK's Nucala (Mepolizumab) Shows Promise in COPD Treatment, Regulatory Submissions Underway
去年
GSK's Nucala (Mepolizumab) Approved in China for Chronic Rhinosinusitis with Nasal Polyps
去年
FDA Misses Review Deadline for GSK's Nucala COPD Expansion Amid Regulatory Delays
2年前
GSK's Nucala Shows Promise in Reducing COPD Flare-Ups
去年
FDA Approves GSK's Nucala for COPD Treatment, Expanding Therapeutic Options
去年
FDA Approves GSK's Nucala for COPD Treatment, Expanding Options for "Smoker's Lung"
2年前
GSK's Depemokimab Shows Promise in Severe Asthma with Six-Month Dosing
7个月前
GSK Completes Long-Term Real-World Study of Nucala in Rare Eosinophilic Disease EGPA
去年
FDA Rejects AstraZeneca's Fasenra for Nasal Polyp Treatment, Additional Clinical Data Required
第 1 页,共 11 页
上一页
下一页